Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Downgrades Mesoblast to Hold

Jefferies Downgrades Mesoblast to Hold

Jefferies analyst David Stanton downgrades Mesoblast (NASDAQ:MESO) from Buy to Hold.

byBenzinga Newsdesk

December 6, 2022

1 minute read

Jefferies analyst David Stanton downgrades Mesoblast (NASDAQ:MESO) from Buy to Hold.

Analyst Ratings

Analyst Ratings for Avantor

By Benzinga Insights

June 21, 10:03 AM

Within the last quarter, Avantor (NYSE:AVTR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

AVTR

Analyst Ratings

Where HCA Healthcare Stands With Analysts

By Benzinga Insights

July 28, 10:00 AM

Analysts have provided the following ratings for HCA Healthcare (NYSE:HCA) within the last quarter: Bullish Somewhat Bullish Indifferent…

HCA

Analyst Ratings

Evaluating Lantheus Holdings: Insights From 5 Financial Analysts

By Benzinga Insights

May 3, 10:01 AM

Lantheus Holdings (NASDAQ:LNTH) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from…

LNTH

Elon Musk Visits Japan After Nearly A Decade — Here’s Where He Went In Tokyo

By Benzinga Neuro

August 17, 11:59 PM

Elon Musk visits Japan for the first time in nine years, amidst significant developments in the electric vehicle market and demographic challenges in the country, potentially influencing Tesla's regional strategy.

BYDDF

Jefferies Downgrades Mesoblast to Hold

Related Posts

Analyst Ratings for Avantor

Where HCA Healthcare Stands With Analysts

Evaluating Lantheus Holdings: Insights From 5 Financial Analysts

Elon Musk Visits Japan After Nearly A Decade — Here’s Where He Went In Tokyo